Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Device Angel Investors in Europe in January 2026

Last updated: Jan 2026 A list of 50 angel investors that invest in Medical device startups based in Europe. We rank investors based on the number of investments they made in Medical device companies from Europe. We update this investor list every month.

Top 50 Medical Device Angel Investors in Europe in January 2026

Investor	Medical Device Europe investments
Pierre Rigaux	4
Yann Fleureau	3
Paul Heydon	3
Sophia Bendz	3
Simanta Das	3
Schnidar Harald	3
Tim Jackson	2
Stine Molgaard Sorensen	2
Luca Trevisan	2
Carlos Gallardo	2
Chris Gasteratos	2
Ragnar Sass	2
Ariel Poler	2
Guillaume Richard	2
Dino Giusti	2
Martin Tajur	2
Tim Dempsey	2
Barbara Castellano	2
Hampus Jakobsson	2
Ali Omar	2
Chip Hance	2
Mark Bamforth	2
Ilkay Gundogan	2
Daniel Caille	2
Juan Knuth	2
Peter Bruhn	1
Peter Sandberg	1
Charlie Songhurst	1
Henrik Schunk	1
Leonid Shapiro	1
Yusuf Hamied	1
Fabio Faltoni	1
Yves Beudin	1
Paul Thandi	1
Silke Rickert Sperling	1
Martin Schödel	1
Matthias Hilpert	1
Steen Thygesen	1
Inaki Berenguer	1
Jacques Gardette	1
Gert Jan van der Hoeven	1
Pierre Olivier Goineau	1
Florian Meissner	1
Caroll H. Neubauer	1
Ferrante Gaetani,	1
Maximilian Reiter	1
Cliff Emmons	1
Pierre-Jean Lamps	1
Christoph Behn	1
Richard Duncalf OBE JP	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Pierre Rigaux

Investment focus

Sports, Medical Device
Seed, Pre-Seed, Convertible Note
Belgium

Portfolio highlights

MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.

Yann sets the vision and strategic direction for Cardiologs and is the guardian of company culture. He is a frequent speaker at industry conferences and is recognized as a thought leader in the application of AI in healthcare. Yann graduated with a degree in Computer Science and Biology from Ecole Polytechnique Paris (X) and the Silicon ValleyInnovation and Entrepreneurship program at UC Berkeley.He was recently named one of MIT Technology Review's Innovators Under 35 in Europe and BNP Paribas European Innovator of the Year. Yann is passionate about the intersection of new technology & clinical practice and is excited to be building a leading company that will help usher in a new era for healthcare worldwide.

Investment focus

Health Care, Medical Device, Artificial Intelligence
Series A, Series B
France

Portfolio highlights

Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.
Brink Therapeutics — Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases.

I have 30+ years as a founder, operator, investor, board member and advisor. I have founded/co-founded multiple companies and have dealt with cofounder issues directly. I have invested in individual companies that have achieved $2b in revenue, $1b in profit, $30b in valuation. Plus on the other side of the spectrum, I have seen lots ofdifferent poor behaviour by some investors, founders and lawyers. My value add is: - the ability to quickly filter out the wrong people. - fundraising - strategy - focus - making tough decisions - cashflow planningCurrently investing directly in startups (mainly tech) at all stages and in funds (most asset classes) as an LP globally. I invested early in Supercell (majority acquired by Tencent), Unity Software (NYSE:U), Radiant Entertainment (acquired by Riot Games), Boomlagoon (acquired by Wargaming), Peak (acquired by Hachette Livre), Gameclub (acquired by Take-Two Interactive), Doppio Games (acquired by Fortis). Previously, I cofounded a seed VC firm & was an investment banker at various firms. I have both a HBA & MBA from the Richard Ivey School of Business at University of Western Ontario in Canada.If you message me with a pitch deck link for your company or fund then do not send me a docsend link or anything requesting an email and or password as I will ignore it. And make sure you detail the team background, why it’s the best team and why you will win.I’m also open to board positions for companies in Europe and North America. Owner of https://www.heathfieldestatenewforest.co.uk/

Investment focus

Software, Gaming, Mobile Apps
Seed, Series A, Pre-Seed
United States, United Kingdom, Finland

Portfolio highlights

Astral — Create a free website/link-in-bio to market your art, release new music, increase your followers, sell merchandise, and share your portfolio/resume/EPK. Token Gate all.
Coherence — Unlock your multiplayer possibilities
Glean AI — Glean AI is the only Accounts Payable solution that combines smart automation with spend intelligence and powers Finance teams to drive material savings.

Sophia Bendz - Partner @ Cherry Ventures

Investment focus

Health Care, Software, Apps
Seed, Pre-Seed, Funding Round
Sweden, United Kingdom, United States

Portfolio highlights

mayk — Mayk sounds. Mayk music. Mayk noise. Mayk it... In an app.
Medoma — Medoma is a Swedish virtual ward company that offer patients acute hospital care in their home instead of in the hospital.
Wikifarmer — A free online knowledge library where professional or amateur farmers can find best practices on growing their fields more effectively and an online marketplace where farmers can sell their products to buyers directly. Our vision is to create a fair, transparent and profitable environment for all the farming world. Farmers are dedicating theirlives in cultivating their fields, but get the lowest value of all the sales cycle, so we believe they need to receive a more fair share. Buyers have the right to have more options and buy at better prices, so we want to be the ones to solve this inequality in both sides.

Simanta Das is a Managing Partner at Stalhmarg and Founder of Rising Stars Ventures.

Investment focus

Health Care, Apps, Education
Seed, Angel, Pre-Seed
Greece, United Kingdom, The Netherlands

Portfolio highlights

RTsafe — RTsafe provides personalized care in radiation oncology by combining proven expertise in medical physics and highly accurate 3D printing technology. Through its innovative products which include remote dosimetry services and 3D printed dosimetry phantoms, built from real patient anatomical data, supports radiotherapy professionals and significantly enhances patient safety.
Fika — Fika provides guided soft skills micro-training that integrates easily into your work calendars and existing meetings. Book your free Fika trial.
NeuroReality — NeuroReality is developing Koji’s Quest, a unique VR-based SAAS solution that puts the patient at the center of the rehabilitation experience & connects all key stakeholders by providing patients with better health outcomes, allowing clinicians to deliver superior care to more patients without increasing care costs, & permits insurancecompanies to save money while improving care standards. NeuroReality registered 19-12-2017 and is working with a team of 12 devoted developers, neuroscience researchers, creatives and business developers.

Entrepreneur, Angel Investor, Scientist and Inventor

Investment focus

mHealth, Software, Biopharma
Seed, Angel, Pre-Seed
Austria

Portfolio highlights

SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.

Tim Jackson is the Founder, CEO, General Partner & Partner of Walking Ventures & he attended University of Oxford in in 1983.

Investment focus

Software, Internet, E-Commerce
Seed, Angel, Pre-Seed
United Kingdom, United States, Sweden

Portfolio highlights

Cera — In five years, Cera has expanded to 10,000+ staff across the UK and Germany, delivering 40,000+ healthcare visits a day, and has grown from zero to nearly $300M revenues. Every day, Cera delivers healthcare services equivalent to several dozen hospitals or 1,000 care homes, and has grown 100-fold over the past two years making it one of the fastestgrowing businesses in Europe.Cera currently holds more than 300+ partnerships with the NHS and local authorities, and the company’s technology is used by 2,000+ businesses nationwide. It’s technology predicts health deteriorations in patients 30-fold faster than traditional care companies, with its Professional Carers and Nurses responding to over 5,000 ‘high risk’ alerts each day.Since the outset of the COVID-19 pandemic, Cera has delivered 10 million healthcare visits in people’s homes, created 10,000 jobs, and licensed it’s recruitment technology to the UK Government Department of Health to recruit 50,000+ people into healthcare careers. Cera was co-founded by entrepreneur, physician and policy expert Dr Ben Maruthappu, and its advisory board is chaired by Sir David Behan, the former CEO of the Care Quality Commission. Cera’s technology and care network have been recognised by over 30 industry awards including Deloitte Fast 50 (#8 in 2021, down from #26 in 2020), Sunday Times Fast Track and Most Outstanding Home Care Provider.
CloudNC — CloudNC CAM Assist your CAM programming co-pilot. Automate your CAM programming. From setup to CAM program in seconds for 3-axis prismatic parts.
Credit Kudos — Credit Kudos builds products using Open Banking so credit providers can approve more people and lower risk. Explore now!

Stine Molgaard Sorensen is the Co-founder and COO of Radiobotics.

Investment focus

Robotics, Software, Health Care
Pre-Seed, Seed, Funding Round
Denmark

Portfolio highlights

RiACT — Software for robots. Real-time development platform for creators and users of flexible robot applications.
NordInsight — Instantly access MRI safety conditions, generate CPT-code ready reports, and standardize your workflow. NordInsight empowers radiology professionals with the tools they need to ensure safe, fast, and compliant MRI scans across all implants.
Radiobotics — Our flagship product RBfracture is able to detect fractures in X-rays across the entire appendicular skeleton, and is MDR IIa certified. Also available: RBhip, RBknee and RBmarker

Luca Trevisan Sales Manager and Business Coordinator.

Investment focus

Medical, Health Care, Medical Device
Series A
Italy

Portfolio highlights

I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.

Carlos Gallardo

Investment focus

Health Care, Medical Device, Medical
Seed, Series A
Spain, United Kingdom

Portfolio highlights

Amelia Virtual Care — Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Chris Gasteratos

Investment focus

Software, Medical Device, Gaming
Pre-Seed, Seed
United Kingdom, Sweden, Estonia

Portfolio highlights

Acorai — Acorai is developing a device for heart failure management through non-invasive intracardiac pressure monitoring (ICPM), to help reduce hospitalizations and readmissions. Our product, The Acorai Heart Monitor, can monitor mean pulmonary artery pressure (mPAP) non-invasively through a machine learning analysis of pressure dynamics in acoustics,vibratory and waveform data. Our technology show compelling precision, has a low-risk clinical and regulatory pathway, a low dependence on reimbursement and a fast track to commercialization. With a team with more than 50 years of industry experience, we can help heart failure patients live longer, healthier, and less uncertain lives.Acorai was founded in 2019 and is headquartered in Skane, Sweden.
ODIN Space — ODIN Space provides mission-critical intelligence for the entire Space sector,
Intryc — Sample tickets, evaluate human and AI agents, and unlock customer insights with the power of AI with Intryc.

Ragnar Sass is the Co-Founder of Darkstar Camp. He previously worked at LIFT99 as a Founder and CEO. Ragnar Sass attended Estonian Business School.

Investment focus

Information Technology, Software, SaaS
Seed, Pre-Seed, Funding Round
Estonia, United States, Ukraine

Portfolio highlights

Alvin — Highly accurate, automated column-level lineage, powering your data workflows.
BeTRITON — 100% electric recreational vehicle - revolution in sustainable travel. BeTRITON (formerly known as Z-Triton) offers extraordinary experience and freedom to travel both over land and water.
Around — The largest network of workspaces on flexible terms. We are a savvy team from Latin America providing fast-growing companies with on-demand access to flexible office space. Everywhere.We believe work at its best is always creative and collaborative, expressed with freedom, autonomy, and purpose; and the space surrounding us should help us achieveit, anywhere & everywhere.We are shaping the future of work today by improving workspaces and the rules around them, and helping innovative teams find their ideal space to make their best work every day — our first step on a journey to change the way we work and think about work.Our best work. Anywhere. Everywhere. We are Around.

Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.

Investment focus

Software, Social Media, Internet
Seed, Series A, Angel
United States, Spain, Mexico

Portfolio highlights

Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
Kiwibot — Delivery robots to optimize your business and deliver safely and timely to your customers.
Grin Scooters — Grin Scooters is a software company that operates network of operational shared electric scooters. Currently, Grin only operates in Mexico City, Guadalajara, Monterrey, Sao Paulo and Bogota but it has plans to expand to other cities throughout Latin America.

Guillaume Richard is the Founder, Chairman & CEO at Oui Care.He attended EDHEC Business School.

Investment focus

Medical, Software, Health Care
Pre-Seed, Series A
France

Portfolio highlights

HYPNO VR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.

Dino Giusti

Investment focus

Wellness, Health Care, Medical Device
Seed
Italy

Portfolio highlights

Euleria Health — Devices and technologies for more accessible and measurable rehabilitation and telerehabilitation at the service of clinics and movement experts, in the clinic and at home.

Martin Tajur is the co-founder of Pipedrive.

Investment focus

Software, SaaS, Recruiting
Pre-Seed, Seed, Angel
Estonia, Poland, Ukraine

Portfolio highlights

YuMuuv — YuMuuv is an employee wellness platform that uses science-based formulas to capture data and keeps track of physical activity & leaderboard.
Shen.AI — Discover how Shen AI turns your smartphone into a health companion - no wearables, just powerful, camera-based health insights.
SegmentStream — SegmentStream is a data intelligence platform which helps collect and unify from different data sources into own data warehouse for advanced analytics and attribution. Our solution is trusted by leading brands such as Benetton, Nespresso, New Balance, myToys, Eventim Group, and others.

Tim Dempsey is a Managing Partner at Epiphany Capital. He graduated from the University of Manchester.

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
United Kingdom

Portfolio highlights

Lunio — Say goodbye to wasted ad spend and false conversions. Use Lunio to stave off click fraud and invalid users, safeguarding the quality of your traffic and driving better returns from paid media
Mitra bio — We are transforming skin-care by approaching ageing as a disease to be fought. We are developing a genetic and epigenetic discovery platform to help skincare companies find and develop new compounds that actually fight the root cause of skin ageing.
PPC Protect — Say goodbye to wasted ad spend and false conversions. Use Lunio to stave off click fraud and invalid users, safeguarding the quality of your traffic and driving better returns from paid media

Laura Iris Ferro

Investment focus

Health Care, Biotechnology, Medical Device
Pre-Seed, Funding Round
Italy

Portfolio highlights

Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
Bio4Dreams — Il primo incubatore italiano certificato di startup innovative in fase very early stage, a capitale totalmente privato, dedicato alle Scienze della Vita.
CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.

Hampus Jakobsson is a General Partner at early stage climate tech venture fund Pale Blue Dot.Prior to co-founding Pale Blue Dot, Hampus was a Venture Partner at science fund Blue Yard and a prolific angel investor with >100 angel investments. He co-founded of The Astonishing Tribe (acquired by Blackberry in 2010 for $150m). He left Blackberry2012 to found Brisk.io a sales productivity tool which folded 2016.

Investment focus

Health Care, Software, Mobile
Seed, Angel, Series A
Sweden, Denmark, United States

Portfolio highlights

ClimateView — ClimateView is a Swedish climate action technology company that helps cities transform climate planning into progress. We combine data, agent-based modelling and interface design to help cities successfully manage the transition to zero carbon economies.
Mojo — Clinical-grade, AI-powered sperm analysis from the comfort of home. Test your sperm count, motility, morphology and much more with the Mojo kit. Check your fertility from home at low cost - without the need for clinic visits and awkward waiting rooms.
Volta Greentech — Battling global warming by reducing methane emissions from cows

Ali Omar is a Member of the Finnish Business Angels Network. He attended Aalto University and the University of Oulu.

Investment focus

Software, SaaS, Artificial Intelligence
Seed, Pre-Seed, Angel
Finland, United States, Estonia

Portfolio highlights

Themo — Themo's innovation is an algorithm that optimizes the price of exchange electricity and the consumption of electricity. Themo offers an easy and environmentally friendly way to save on electricity consumed by heating.
GoalProfit — GoalProfit is the world’s first low code retail optimization platform empowering retailers to build customized intelligence applications. It was founded by former IBM executives, Maxim Morozov and Oleg Sidorkin. GoalProfit is on a mission to make big data solutions available for all retailers and help them to survive in a new post-covid reality.
Builderhead — Builderhead is an easy-to-use construction management software that helps owners, developers and general contractors complete construction projects on time and within budget.

Chip Hance

Investment focus

Medical, Health Care, Medical Device
Series A, Funding Round
Ireland

Portfolio highlights

Signum Surgical — A minimally invasive approach to primary Fistula healing through tissue apposition, without compromising the anal sphincter.

Mark Bamforth is the Operating Partner at Ampersand Capital Partners.

Investment focus

Health Care, Medical, Biotechnology
Series A, Funding Round, Seed
United Kingdom, United States

Portfolio highlights

Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
PneumoWave — PneumoWave is developing real-time monitoring solutions to allow patients with respiratory conditions and their doctors to track their respiratory rates and performance out of hospital, at home and at work. Combining proprietary sensor technology and an innovative AI driven digital therapeutic software platform, PneumoWave's technologyenables doctors to rationalise medication use, identify early signs of deterioration, reduce or shorten hospital admissions and reduce face to face appointments.
Thymmune Therapeutics — Thymmune Therapeutics is developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.

Ilkay Gundogan

Investment focus

Health Care, Apps, Printing
Seed, Pre-Seed, Funding Round
United Kingdom, Turkey

Portfolio highlights

WeWALK — WeWALK is on a mission to enhance our visually impaired community's safety, independence, and social inclusion through mobility tech.
Terra API — API that enables you to integrate with wearables, such as Garmin, Fitbit, Apple, Google, Polar, Eight Sleep, Oura and Others through a single source.
Onchain labs — Onchain Labs offers scalable Web3 software-as-a-service solution for blockchain technology accessibility. OnchainLabs aims to revolutionize businesses by integrating blockchain technology into every aspect of their operations, fostering innovation, transparency, and trust. Their cutting-edge services aim to be the premier partner for businessesseeking to harness blockchain's transformative potential.

Daniel Caille

Investment focus

Elderly, Medical, Software
Series A, Pre-Seed, Funding Round
France

Portfolio highlights

HYPNO VR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
Medylink —
CetteFamille — CetteFamille is an economical alternative to retirement homes in France. It is a French network of professional and accredited families to welcome the elderly.CetteFamille is a warm, economical and tailor-made alternative to the retirement home. CetteFamille is a site of connection and a company of services to the person allowing seniors to finda trained and selected family close to home. CetteFamille offers seniors and their families an offer of contact and a follow-up service to carry out all the administrative procedures.On www.cettefamille.com, caregivers of seniors can register to meet a family available nearby. The teams at CetteFamille are responsible for contacting them to study the request and ensure a meeting with the family most appropriate to meet his needs.

Juan Knuth

Investment focus

Health Care, Biotechnology, Digital Media
Seed, Series A
Spain

Portfolio highlights

Devicare — Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The company's medical devices are useful in measuring the level of biomarkers in body fluids such as saliva, tears, sweat, sputum, feces, urine or blood, enabling medical professionals to detect and treat various infectious diseases.

Peter Bruhn is a Senior Digital Leader and Digital Transformation Specialist. His experience includes Senior Digital Advisor at TAKKT AG, Consultant at McKinsey & Company, Senior Manager at Deutsche Telekom AG.

Investment focus

Health Care, Medical Device
Seed
Germany

Portfolio highlights

TreasureHunter —
icho systems — ichó is the smart therapy system for people with neurological conditions such as dementia, stroke or Parkinson's disease.The therapeutic care of these patients is already a major challenge today. Due to demographic change and a shortage of skilled labour, there is a risk of undersupply. The innovative medical device, the ichó therapy ball,provides patients with a smart device that stimulates and guides them in the implementation of therapeutic measures. The ichó applications give patients access to guideline-compliant therapy programmes, while the smart patient monitoring transparently displays the therapy process with real-world data.While smartphone apps or tablet solutions are already a challenge for patients to use, ichó has been specially developed for people with cognitive and motor impairments. The smart therapy ball recognises all interactions such as rolling, catching or shaking and reacts with coloured light, sound or music depending on the programme. Together with therapists, there are over 150 guideline-compliant therapy applications that stimulate patients' cognitive and motor skills. The effectiveness of ichó is confirmed by medical professionals and evaluations.Since its market launch in 2020, ichó has already been used in over 850 facilities. In mid-2023, based on the evaluations, the ichó therapy programme was funded by the care insurance funds for the first time as a preventive service in accordance with Section 5 SGB XI.The goal of ichó is to provide outpatient care for all patients at home.

Peter Sandberg is a Co-Founder of Nordic Secondary Fund, and a venture partner at Startup Wise Guys. He has extensive experience as a Business Angel, Asset Management and Wealth Management

Investment focus

Internet, Mobile Payments, Artificial Intelligence
Angel, Pre-Seed, Secondary Market
Denmark, Kenya, Estonia

Portfolio highlights

TRAPMINE — TRAPMINE Endpoint Protection Platform provides fool-proof defense against malware, exploit attempts, file-less malware, ransomware and other forms of targeted attacks.Unlike traditional detection-based approaches like legacy antivirus, TRAPMINE combines proven and innovative technologies such as deep learning, behavior monitoring, endpointdeception and anti-exploit techniques to block cyber threats dead in their tracks. TRAPMINE's easy-deploy and lightweight solution comes with a comfortable built-in security console, at a price/performance ratio unmatchable even by the biggest names in Palo Alto.Why TRAPMINE?Cyber criminals target companies of all sizes from every industry, seeking anything that might be of value. Antivirus and other traditional security solutions are no longer efficient to protect organizations from attacks by today’s modern cyber threat actors. That’s why we founded TRAPMINE. TRAPMINE is created to solve the malware problem for all organizations at a reasonable price.
Colibo A/S — Use Colibo's intranet software as your enterprise collaboration platform to increase productivity, drive employee engagement and better internal communications.
November First — November First - Betalingsplatform til alle virksomheder

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, United States, Germany

Portfolio highlights

Skrap — Skrap is an on-demand mobile marketplace for skip hire and other waste collection services.
Forgent AI — Forgent uses AI agents to draft tender proposals, find opportunities and coordinate teams.
Hyphen SCS — Building India's Biggest warehousing & Fulfilment Platform

Henrik Schunk, the CEO of SCHUNK GmbH & Co.

Investment focus

Internet, Software, Internet of Things
Series A
Germany

Portfolio highlights

Cybus — Cybus is an industrial IoT company founded in Hamburg in 2015.The goal of the team around Pierre Manière, Marius Schmeding and Peter Sorowka is to make the interconnected digital economy of the future reality by making real-world data universally usable within and between organisations.Manufacturing companies use the “Cybus Connectware”software solution to implement their multiple Smart Factory use cases with any machine and any application – for example for quality management, condition monitoring or predictive maintenance. The key feature: Thanks to state-of-the-art data management, users always keep full control over their production data as new digital asset. At the same time, service providers and machine builders use the software as a secure gateway for their customers to concentrate on their digital applications and services.
Reactive Robotics — Reactive Robotics was founded as a GmbH in Munich, Germany, in April 2015. Their team has a combined 12 years of rehabilitation robotics research, vast startup experience and a large clinical network to bring this device to life. They are proud to feature an excellent array of supporters that provide advice on every level required for thesuccessful start-up of a medical technology company. Confirmed advisors provide access to patients, support them in engineering, on legal issues and when dealing with the details of registering a medical device with the authorities.

Leonid Shapiro is a managing partner at Candesic. He is also a partner at Brookstreet Equity Partners. Prior to joining Brookstreet, Leonid served as an engagement manager at McKinsey & Company.

Investment focus

Health Care, Medical Device, Nanotechnology
Seed
United Kingdom

Portfolio highlights

FluoretiQ — FluoretiQ is a medical device company designing simple and effective bacterial detection systems for rapid diagnosis of infection. They developing a new solution that combines proprietary nanomaterials and optical sensing technologies to enable the identification of harmful bacteria in minutes. The company nanotechnology utilizes receptor-mediatedsensing and Quantum-enhanced optics for the rapid identification of bacterial infection.FluoretiQ developed NANOPLEXa rapid diagnostic platform that identifies and enumerates bacterial pathogens in less than 15 minutes. The NANOPLEXa ensures that patients receive the most effective antibiotic treatment from the start. Their products easy-to-use, providing clinicians with the data to support accurate-same-day diagnosis and more appropriate antibiotic selection.FlouretiQ was founded in 2017 and is headquartered in Bristol, United Kingdom.

Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.

Investment focus

Medical, Medical Device
Seed
United Kingdom

Portfolio highlights

1inhaler — 1inhaler operates as a developer of drug delivery device.

Fabio Faltoni is the President of Kell.

Investment focus

Medical, Health Care, Medical Device
Series A
Italy

Portfolio highlights

I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.

Yves Beudin

Investment focus

Medical, Health Care, Biotechnology
Angel
Belgium

Portfolio highlights

OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.

Paul is the Founder and Chief Executive Officer of the NEC Group, the UK’s leading live events business, which owns; the NEC, ICC, Vox, Resorts World Arena, Utilita Arena Birmingham, The Ticket Factory and Amadeus.He was appointed Group CEO in 2006, bringing over 20 years’ experience in the media industry.Paul has since transformed the Groupinto a customer-centric and data-led organisation, whilst increasing its portfolio of businesses and venues, and leading the company through changes of ownership in 2015 and 2018.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

EDX Medical Group — EDX Medical Group provides innovative digital diagnostic products and services for cancer, cardiovascular disease, neurology, and infectious disease testing.

Silke Rickert Sperling

Investment focus

Robotics, Health Care, Medical Device
Seed
Germany

Portfolio highlights

Sphaira — Precise autonomous mobility for complex environments.

Martin Schödel

Investment focus

Medical, Medical Device, Musical Instruments
Seed
Bulgaria

Portfolio highlights

Flinn — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.

Matthias Hilpert - CEO @ MH2 Capital

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Pre-Seed
Germany, United States, United Kingdom

Portfolio highlights

Workbounce — Workbounce is the co-pilot for customer-facing team connecting tools like Google Drive, Notion, Slack with intelligent search and analytics.
Flinn — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
Atlas Metrics — The single source of truth for your ESG data

Steen Thygesen is the CEO of Audientes. He previously worked at Star as a Managing Director, Nordics. Steen Thygesen attended London Business School.

Investment focus

Medical Device, Product Design
Debt Financing
Denmark

Portfolio highlights

Audientes — Audientes mission is to make quality hearing solutions accessible and affordable to everyone who needs them. In other words, to help hearing-impaired people hear and interact freely. We will achieve this by designing, developing and bringing to market innovative solutions for the millions who simply cannot afford a traditional hearing aid or do nothave access to an audiologist or hearing center. Audientes solutions address a large and growing global market.

Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.

Investment focus

Financial Services, FinTech, E-Commerce
Seed, Angel, Pre-Seed
Spain, United States, United Kingdom

Portfolio highlights

Ukio — Artfully designed fully furnished apartments available for extended stays
Paack — Find the ideal delivery solution to integrate into your e-commerce. We adapt to your business, providing your customers with an amazing experience.
Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.

Jacques Gardette is the Founder & President of Brenus Pharma.

Investment focus

Software, Biotechnology, Medical Device
Series A, Funding Round
France

Portfolio highlights

SURGAR — SURGAR provides a plug-and-play augmented reality software suite for computer-aided laparoscopic surgery.
Brenus Pharma — Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.

Gert Jan has founded H2 in 1991 together with his long time friend Age Hollander. Gert Jan had graduated from his studies at the Delft University of Technology and the Rotterdam School of Management. After his graduations Gert Jan joined McKinsey & Company to work in The Netherlands, Germany and Switzerland. At McKinsey Gert Jan managed theworld wide company diagnostic approach.Gert Jan has built-up the H2 team and has introduced the firm's strong focus on operational value add, including several of the firm's approaches. He is Chairman of the Investment Committee of H2. Gert Jan's passion is to indeed build better companies. The areas of his knowledge include consumer goods (Lunch Garden), manufacturing (Eska Graphic Board and Meijn), wholesale and distribution (Smartwares).Gert Jan likes to spend time with his family.

Investment focus

Health Care, Medical Device, Personalization
Series A
Greece

Portfolio highlights

RTsafe — RTsafe provides personalized care in radiation oncology by combining proven expertise in medical physics and highly accurate 3D printing technology. Through its innovative products which include remote dosimetry services and 3D printed dosimetry phantoms, built from real patient anatomical data, supports radiotherapy professionals and significantly enhances patient safety.

Pierre Olivier Goineau - President @ Neuronax

Investment focus

Medical, Biopharma, Health Care
Funding Round
France

Portfolio highlights

Ixaltis — Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.The company was born out of the combined expertise of scientists specialized in urology, pharmaceutical experts and experienced managers: Dr. Philippe Lluel, Christian Chavy, Stefano Palea, Dr. Roberto Gradnik andProfessors Pascal Rischmann and Xavier Gamé. The vision of IXALTIS is to develop treatments for genito-urinary tract diseases with still a high unmet medical need, by identifying drugs which had already reached clinical stage and reexplore these for use in genitourinary tract disorders.IXALTIS has established a proprietary position covering Litoxetine for use in urogenital and other disorders based on its specific mechanism of action.

Florian is the Co-Founder and CEO of EyeEm, a global photography community and marketplace. He founded EyeEm in 2011 with friends Lorenz Aschoff, Ramzi Rizk and Gen Sadakane after his digital SLR camera was stolen in a New York subway while working as a photographer. Together, the team grew a small group of photographers into a global community ofover 17 million today. Flo has been featured in the Wall Street Journal, the New York Times, Forbes Magazine, and Wired Magazine among others and is an avid speaker on technology, entrepreneurship and the future of the photography industry. Florian studied business in Berlin, London and Vienna.

Investment focus

EdTech, Software, Information Technology
Seed
Germany

Portfolio highlights

Lottie — Lottie's mission is to change the way young kids experience technology and to bring peace of mind to parents, by building a magical experience that the whole family can love.
Sphaira — Precise autonomous mobility for complex environments.

Caroll H. Neubauer is the Member of The Supervisory Board of Zimmer MedizinSysteme. He attended Georgetown University Law Center.

Investment focus

Robotics, Health Care, Medical Device
Seed
Germany

Portfolio highlights

Sphaira — Precise autonomous mobility for complex environments.

Ferrante Gaetani,

Investment focus

Medical, Health Care, Medical Device
Series A
Italy

Portfolio highlights

I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.

Maximilian Reiter

Investment focus

Medical, Medical Device, Musical Instruments
Seed
Bulgaria

Portfolio highlights

Flinn — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.

Cliff Emmons is the Chief Executive Officer of Oxys.

Investment focus

Medical, Health Care, Medical Device
Seed
Ireland

Portfolio highlights

Gasgon Medical — Medical device start-up | Improving healthcare with advanced IV technology | Infused With Confidence | Cork, Ireland.

Pierre-Jean Lamps

Investment focus

Software, Medical Device, Augmented Reality
Funding Round
France

Portfolio highlights

SURGAR — SURGAR provides a plug-and-play augmented reality software suite for computer-aided laparoscopic surgery.

Christoph Behn is the Chairman & Founder of better ventures. He previously worked at Die Kartenmacherei as an Advisory Board & Founder. Christoph Behn attended HHL Leipzig Graduate School of Management.

Investment focus

Software, Advanced Materials, Manufacturing
Pre-Seed, Seed, Funding Round
Germany

Portfolio highlights

42 Watt — 42 Watt is an energy conservation consultancy which strives to reduce costs, save energy and protect the climate.
Halitus — Laser Technology x Gas Dynamics Analysis x Machine Learning.
Strollme — Strollme believes in idea of using resources wisely, they started with stroller which can be reused for next time.

Richard Duncalf OBE JP

Investment focus

Wellness, Health Care, Mental Health
Pre-Seed
United Kingdom

Portfolio highlights

Voda — Voda is the LGBTQIA+ mental wellbeing app developed with leading LGBTQIA+ psychotherapists. We're on a mission to help members of the LGBTQIA+ community lead more fulfilled and thriving lives through affordable, accessible and intersectional digital therapy.Voda's self-guided therapy programs are up to 24x more affordable than privatetherapy.

Investors by industry

Community

Artificial intelligence